Quest Diagnostics Reports Strong Q1, Raises Guidance
Tap title to read story
SECAUCUS, N.J. — Quest Diagnostics reported first-quarter 2026 results on April 21, 2026, announcing net income of about $251–$252 million, GAAP EPS of $2.24 and adjusted EPS of $2.50 on revenue near $2.9 billion. The company also updated full-year adjusted diluted EPS guidance to $10.63–$10.83 and net revenue guidance to $11.78–$11.90 billion.
SECAUCUS, N.J. — Quest Diagnostics reported first-quarter 2026 results on April 21, 2026, announcing net income of about $251–$252 million, GAAP EPS of $2.24 and adjusted EPS of $2.50 on revenue near $2.9 billion. The company also updated full-year adjusted diluted EPS guidance to $10.63–$10.83 and net revenue guidance to $11.78–$11.90 billion.
The results topped Zacks consensus estimates for both earnings and revenue on Tuesday, and management cited roughly 9% organic revenue growth in the quarter when raising guidance. In pre-market trading this week, Quest shares were reported up about 2.39 percent, and analysts and investors will monitor second-quarter trends and execution against the revised 2026 outlook.
More context
Timeline
- 1. March 31, 2026: End of Quest Diagnostics' first-quarter reporting period.
- 2. April 21, 2026: Quest issued Q1 financial results and updated full-year guidance.
- 3. April 21, 2026: Newswire and media outlets (PR Newswire, AP, RTT/dpa-AFX) distributed the results.
- 4. April 21, 2026: Zacks consensus comparison published; results reported to have topped estimates.
- 5. April 21, 2026: Pre-market trading showed Quest shares rising following the guidance update.
Why it matters
Quest Diagnostics' strong Q1 results could impact your wallet. If you own shares, you're likely seeing a boost in your investment. If you're considering investing, this might be a company to watch. Check your portfolio or speak with your financial advisor.
Sources
JQJO Editorial Desk · Human reviewed · AI assisted. Report a correction.
